Mikrogen and Phosphorus Announce Partnership to Provide Holistic, Preventative Genetic Insights to Reproductive Health Services in Turkey.
Retrieved on:
Thursday, February 24, 2022
Genetics, Health, Partnership, Pharmacogenomics, Accreditation, European, Degenerative disease, Preimplantation genetic diagnosis, Diet, Diet (nutrition), Hearing loss, University, Kinesiogenomics, Severe cognitive impairment, Chromosome, Sibling, Organization, Medicine, Genetic testing, Cancer, Exercise, Genomics, Endocrinology, Multimedia, Private, Science, Infertility, HLA, Sleep, Patient, Reproductive medicine, Neurology, State, Solution, CEO, Software, Agriculture, Antibiotics, Phosphorus
For over 20 years, Mikrogen Genetic Diseases Diagnosis Center has delivered reproductive medicine and embryo genetics services.
Key Points:
- For over 20 years, Mikrogen Genetic Diseases Diagnosis Center has delivered reproductive medicine and embryo genetics services.
- "We are excited to have the Mikrogen team as our partner in preventative genetic testing in the Middle East," said Alex Bisignano, Founder and CEO of Phosphorus.
- "We believe the medical-grade depth and accuracy of GeneCompass provides critical information and will seamlessly augment the services Mikrogen already provides."
- Additionally, Phosphorus provides white-labeling genomics-as-a-service solutions by partnering with organizations who want to deploy their own preventative genetic testing solutions.